Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer-Reference-Cited by-同舟云学术

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Published:2013-05-13 Issue:7 Volume:5 Page:1051-1066
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Tan Tuan Zea¹,Miow Qing Hao¹²,Huang Ruby Yun‐Ju¹³,Wong Meng Kang¹,Ye Jieru¹,Lau Jieying Amelia¹,Wu Meng Chu¹,Bin Abdul Hadi Luqman Hakim¹,Soong Richie¹,Choolani Mahesh³,Davidson Ben⁴⁵,Nesland Jahn M.⁴⁵,Wang Ling‐Zhi¹⁶,Matsumura Noriomi⁷,Mandai Masaki⁷,Konishi Ikuo⁷,Goh Boon‐Cher¹⁶⁸,Chang Jeffrey T.⁹,Thiery Jean Paul¹¹⁰¹¹,Mori Seiichi¹¹¹¹²¹³

Affiliation:

1. Cancer Science Institute of SingaporeNational University of SingaporeSingapore

2. NUS Graduate School for Integrative Sciences and EngineeringNational University of SingaporeSingapore

3. Department of Obstetrics and GynecologyNational University Health SystemSingapore

4. Division of PathologyNorwegian Radium Hospital Oslo University HospitalOsloNorway

5. Faculty of MedicineUniversity of OsloInstitute of Clinical MedicineOsloNorway

6. Department of PharmacologyNational University of SingaporeSingapore

7. Department of Obstetrics and GynecologyKyoto UniversityKyotoJapan

8. Department of Hematology and OncologyNational University Health SystemSingapore

9. Department of Integrative Biology and PharmacologyUniversity of Texas Health Science Center at HoustonTXUSA

10. Institute of Molecular and Cell BiologyA*STAR (Agency for ScienceTechnology and Research)Singapore

11. Department of BiochemistryNational University of SingaporeSingapore

12. Division of Cancer GenomicsCancer Institute of Japanese Foundation for Cancer Research3‐8‐31 AriakeKoto‐ku, TokyoJapan

13. Present Address: Division of Cancer GenomicsCancer Institute of Japanese Foundation for Cancer ResearchKoto‐kuTokyoJapan

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emmm.201201823

Reference79 articles.

1. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

2. Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors

3. Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

4. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1

5. The biology of ovarian cancer: new opportunities for translation

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platforms;2023-11-04

2. UGDH promotes tumor-initiating cells and a fibroinflammatory tumor microenvironment in ovarian cancer;Journal of Experimental & Clinical Cancer Research;2023-10-19

3. DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP Inhibitors;Cancer Research Communications;2023-10-16

4. High-grade serous ovarian carcinoma, the “Achiles’ hill” for clinicians and molecular biologists: a molecular insight;Molecular Biology Reports;2023-09-22

5. Molecular typing and prognostic risk models for ovarian cancer: a study based on cell differentiation trajectory;Frontiers in Cell and Developmental Biology;2023-08-31